Timing and Patterns of Relapse‐Related Events Following Adjuvant <scp>CDK4</scp> /6 Inhibitors Combined With Endocrine Therapy in Patients With <scp>HR</scp> ‐Positive, <scp>HER2</scp> ‐Negative Early Breast Cancer

Huihui Chen, Shijie Wu, Yangyang Shan, Xianan Guo, Wei Lu, Yiding Chen, Yunxiang Zhou

Open source

DOI
10.1002/cam4.72224
Published
2026-08
Container
Cancer Medicine
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cam4.72224,
  title = {Timing and Patterns of Relapse‐Related Events Following Adjuvant
                    <scp>CDK4</scp>
                    /6 Inhibitors Combined With Endocrine Therapy in Patients With
                    <scp>HR</scp>
                    ‐Positive,
                    <scp>HER2</scp>
                    ‐Negative Early Breast Cancer},
  author = {Huihui Chen and Shijie Wu and Yangyang Shan and Xianan Guo and Wei Lu and Yiding Chen and Yunxiang Zhou},
  year = {2026},
  journal = {Cancer Medicine},
  doi = {10.1002/cam4.72224},
  url = {https://doi.org/10.1002/cam4.72224}
}

RIS

TY  - JOUR
TI  - Timing and Patterns of Relapse‐Related Events Following Adjuvant
                    <scp>CDK4</scp>
                    /6 Inhibitors Combined With Endocrine Therapy in Patients With
                    <scp>HR</scp>
                    ‐Positive,
                    <scp>HER2</scp>
                    ‐Negative Early Breast Cancer
AU  - Huihui Chen
AU  - Shijie Wu
AU  - Yangyang Shan
AU  - Xianan Guo
AU  - Wei Lu
AU  - Yiding Chen
AU  - Yunxiang Zhou
PY  - 2026
JO  - Cancer Medicine
DO  - 10.1002/cam4.72224
UR  - https://doi.org/10.1002/cam4.72224
ER  - 

APA

Chen, H., Wu, S., Shan, Y., Guo, X., Lu, W., Chen, Y., & Zhou, Y. (2026). Timing and Patterns of Relapse‐Related Events Following Adjuvant <scp>CDK4</scp> /6 Inhibitors Combined With Endocrine Therapy in Patients With <scp>HR</scp> ‐Positive, <scp>HER2</scp> ‐Negative Early Breast Cancer. Cancer Medicine. https://doi.org/10.1002/cam4.72224

Source records